Third, the lack of a thorough evaluation of the additional immune, inflammation, and nutritional chemokines and cytokines, like the C-reactive protein, IL-6, anemia status, and weight loss at the past 6 or 12 months restricted our ability to resolve the potentially valuable interactions between the ALI and these markers. The gene discussed is CRP; the disease is anemia (phenotype).